MedPath

A study to relieve the Symptoms of allergic rhinitis using constitutional medicine and assess the improvement using rhinitis control assessment test scale and absolute eosinophil count

Phase 3
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2024/07/070108
Lead Sponsor
Post Graduate Research Funded By College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having symptomatology of allergic rhinitis.

Age group between 5 - 55 years.

Both sexes.

Patients without the complications of allergic rhinitis such as effusion formation in sinuses, edema of lids, cobble stone conjunctiva, serous otitis media, conductive hearing Loss, granular pharyngitis, bronchial asthma.

Exclusion Criteria

Patients suffering from other severe systemic diseases.

Cases in which surgical intervention becomes necessary.

Pregnant women or breast-feeding individuals may be excluded

Allergic rhinitis associated with any chronic and systemic disease on active treatment.

Exclude severe controlled diabetes.

Severe underlying medical conditions such as immunodeficiency disorders, autoimmune diseases or malignancies.

Patients with the complications of allergic rhinitis such as effusion formation in sinuses, edema of lids, cobble stone conjunctiva, serous otitis media, conductive hearing loss, granular pharyngitis, bronchial asthma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath